TRANSFARMA Trademark

Trademark Overview


On Friday, June 21, 2002, a trademark application was filed for TRANSFARMA with the United States Patent and Trademark Office. The USPTO has given the TRANSFARMA trademark a serial number of 76423697. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 1, 2009. This trademark is owned by Zuellig Pharma Holdings Ltd.. The TRANSFARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of disorders of the respiratory system, gastrointestinal system, neuromuscular system, cardiovascular system; pharmaceutical preparations for the treatment of migraine; vitamin and mineral supplements; dermatological topical preparations for the treatment of skin disorder sand dermatological conditions, excluding pharmaceutical preparations for the treatment of fibrotic tissue disorders and scarring
transfarma

General Information


Serial Number76423697
Word MarkTRANSFARMA
Filing DateFriday, June 21, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 1, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of disorders of the respiratory system, gastrointestinal system, neuromuscular system, cardiovascular system; pharmaceutical preparations for the treatment of migraine; vitamin and mineral supplements; dermatological topical preparations for the treatment of skin disorder sand dermatological conditions, excluding pharmaceutical preparations for the treatment of fibrotic tissue disorders and scarring
Pseudo MarkTRANS FARMA

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 30, 2002
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZuellig Pharma Holdings Ltd.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Address87011 Labuan F.T.
MY

Trademark Events


Event DateEvent Description
Tuesday, September 1, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, September 1, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, February 2, 2009NON-FINAL ACTION MAILED
Friday, January 30, 2009NON-FINAL ACTION WRITTEN
Monday, January 5, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, June 16, 2008REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 16, 2008ASSIGNED TO LIE
Friday, December 7, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 7, 2007REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 1, 2007ASSIGNED TO EXAMINER
Saturday, November 25, 2006REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, November 25, 2006ASSIGNED TO LIE
Thursday, December 29, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 29, 2005LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, June 6, 2005LETTER OF SUSPENSION MAILED
Thursday, June 2, 2005SUSPENSION LETTER WRITTEN
Monday, December 6, 2004LIE CHECKED SUSP - TO ATTY FOR ACTION
Thursday, October 23, 2003CASE FILE IN TICRS
Monday, April 21, 2003LETTER OF SUSPENSION MAILED
Monday, March 31, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 31, 2003PAPER RECEIVED
Friday, November 8, 2002LETTER OF SUSPENSION MAILED
Tuesday, October 8, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2002PAPER RECEIVED
Monday, September 30, 2002NON-FINAL ACTION MAILED
Monday, September 23, 2002ASSIGNED TO EXAMINER